ClinicalTrials.gov
ClinicalTrials.gov Menu

Internet Delivered CBT for Body Dysmorphic Disorder

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02010619
Recruitment Status : Completed
First Posted : December 13, 2013
Last Update Posted : August 18, 2017
Sponsor:
Information provided by (Responsible Party):
Christian Rück, Karolinska Institutet

Brief Summary:
To evaluate if Internet delivered cognitive behavior therapy is an efficacious treatment when compared to a control group consisting of supportive therapy.

Condition or disease Intervention/treatment Phase
Body Dysmorphic Disorder BDD Behavioral: Cognitive behavior therapy Behavioral: Supportive therapy Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 94 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Internet Delivered Cognitive Behavior Therapy for Body Dysmorphic Disorder - a Randomized Controlled Trial
Actual Study Start Date : November 2013
Actual Primary Completion Date : January 2015
Actual Study Completion Date : January 2015

Arm Intervention/treatment
Experimental: Cognitive behavior therapy Behavioral: Cognitive behavior therapy
Active Comparator: Supportive therapy Behavioral: Supportive therapy



Primary Outcome Measures :
  1. Body Dysmorphic Disorder Modification of the Y-BOCS (BDD-YBOCS) [ Time Frame: Change in BDD-YBOCS from baseline (week 0) to post-treatment (week 12) ]

Secondary Outcome Measures :
  1. The Montgomery Åsberg Depression Rating Scale - self report (MADRS-S) [ Time Frame: Change in MADRS-S from baseline (week 0) to post-treatment (week 12) ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • outpatient
  • ≥ 18 years
  • primary diagnosis of BDD according to the DSM-5
  • BDD-YBOCS ≥20
  • regular access to a computer with Internet access and skills to use the web.

Exclusion Criteria:

  • psychotropic medication changes within two months prior to the treatment,
  • completed CBT for BDD within the last 12 months,
  • other primary axis I diagnosis
  • current substance dependence
  • lifetime bipolar disorder or psychosis
  • suicidal ideation
  • Axis II diagnosis that could jeopardize treatment participation,
  • other current psychological treatment that could affect BDD symptoms
  • A serious medical illness that precludes participation in the study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02010619


Locations
Sweden
M46: Karolinska Universitetssjukhuset, Psykiatri Sydväst
Stockholm, Huddinge, Sweden, 141 86
Sponsors and Collaborators
Karolinska Institutet

Publications of Results:
Responsible Party: Christian Rück, Associate professor, M.D., Karolinska Institutet
ClinicalTrials.gov Identifier: NCT02010619     History of Changes
Other Study ID Numbers: BDD RCT
First Posted: December 13, 2013    Key Record Dates
Last Update Posted: August 18, 2017
Last Verified: August 2017

Additional relevant MeSH terms:
Disease
Body Dysmorphic Disorders
Pathologic Processes
Somatoform Disorders
Mental Disorders